Document

TB CAB Open Letter to the European Medicines Agency Re: Conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783)

Recommended citation: TB CAB Open Letter to the European Medicines Agency Re: Conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783). http://www.tbonline.info/media//media/uploads/documents/ema_ddi_open_letter_2012_5_24.pdf

Description

Catalogue: None
Tags: None